Literature DB >> 19003658

Prospective evaluation of the safety and efficacy of the Apogee system for treatment of vault prolapse.

S Balakrishnan1, Y N Lim, C Barry, A Corstians, K Kannan, A Rane.   

Abstract

This is a prospective study evaluating the efficacy and safety of the Apogee vault repair system in the management of vault prolapse. All patients who underwent this procedure between October 2004 and December 2005 in Townsville, Australia are included in the study. Preoperative and postoperative clinical assessments were done using the pelvic organ prolapse quantification (POPQ) system and patients were followed up at 6 weeks, 12 weeks, 6 months, 12 months and then biannually. Of the 35 patients operated, there were no intraoperative complications and only one patient (2.8%) had a recurrence of vault prolapse at 12 months. Nine patients (25%) had mesh exposure treated successfully with outpatient trimming and oestrogen. This medium term study shows that the Apogee procedure is safe with minimal complications for the management of vault prolapse.

Entities:  

Mesh:

Year:  2008        PMID: 19003658     DOI: 10.1080/01443610802355593

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  4 in total

Review 1.  Evaluation of current synthetic mesh materials in pelvic organ prolapse repair.

Authors:  Prashanth Kanagarajah; Rajinikanth Ayyathurai; Christopher Gomez
Journal:  Curr Urol Rep       Date:  2012-06       Impact factor: 3.092

Review 2.  Traditional native tissue versus mesh-augmented pelvic organ prolapse repairs: providing an accurate interpretation of current literature.

Authors:  E J Stanford; A Cassidenti; M D Moen
Journal:  Int Urogynecol J       Date:  2011-11-09       Impact factor: 2.894

Review 3.  Management of recurrent vault prolapse.

Authors:  V V Toh; V Bogne; A Bako
Journal:  Int Urogynecol J       Date:  2011-07-02       Impact factor: 2.894

4.  Mesh repair of vaginal wall prolapse.

Authors:  Krishan Kapur; Vinod Dalal
Journal:  Med J Armed Forces India       Date:  2014-03-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.